Abstract:COVID-19 is a highly contagious disease, which is mainly caused by infected persons with symptoms and thus needs to be prevented from spreading by a large number of control measures. The study on the COVID-19 outbreak in Wuhan will help to understand the transmission characteristics of COVID-19 and help to design and evaluate appropriate prevention and control measures. Based on the data of COVID-19 cases reported in Wuhan from January 20 to March 29, a SEAIC model including asymptomatic infected persons was established. The initial stage of the epidemic was divided into three stages of transmission. The least square method was used to estimate the corresponding characteristic parameters. The results showed that the R0 of the three transmission stages was 5.53, 4.023 and 0.016 respectively. The true proportion of asymptomatic infected is about 7.4%. With the use of the quarantine hospital, R0 quickly dropped below 1 and the epidemic was gradually brought under control.
周武略, 白迪, 赵继军. 武汉市发生的新冠病毒肺炎建模研究分析[J]. 复杂系统与复杂性科学, 2020, 17(4): 58-65.
ZHOU Wulüe, BAI Di, ZHAO Jijun. Modeling and Analysis of COVID-19 in Wuhan. Complex Systems and Complexity Science, 2020, 17(4): 58-65.
[1] 刘霞,娜日莎,毕振强. 新型冠状病毒肺炎疫情防控面临的挑战 [J]. 中华流行病学杂志, 2020, 41(7): E029. Liu Xia, Na Risha, Bi Zhenqiang. Challenges to prevent and control the outbreak of COVID-19 [J]. Chin J Epidemiol, 2020, 41(7): E029. [2] Liu Y, Gayle A A, Wilder-Smith A, et al. The reproductive number of COVID-19 is higher compared to SARS coronavirus[J]. Journal of Travel Medicine, 2020, 27(2): 1-4. [3] 唐三一,肖燕妮,彭志行,等. 新型冠状病毒肺炎疫情预测建模、数据融合与防控策略分析 [J]. 中华流行病学杂志, 2020, 41(4): 480-483. Tang Sanyi, Xiao Yanni, Peng Zhihang, et al. Prediction modeling with data fusion and prevention strategy analysis for the COVID-19 outbreak [J]. Chin J Epidemiol, 2020, 41(4): 480-483. [4] World Health Organization. Coronavirus disease 2019 (COVID-19) situation report-97 [EB/OL]. (2020-04-26)[2020-05-11]. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200426-sitrep-97-covid-19.pdf?sfvrsn=d1c3e800_6. [5] Lipsitch M, Swerdlow D L, Finelli L. Defining the epidemiology of covid-19 - studies needed [J]. N Engl J Med. 2020, 382: 1194-1196. [6] Huang C L, Wang Y M, Li X W, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [J]. The Lancet, 2020,395(10223): 497-506. [7] 张彦平. 新型冠状病毒肺炎流行病学特征分析[J]. 中华流行病学杂志, 2020, 41(2): 145-151. Zhang Yanping. The epidemiological of an outbreak of 2019 novel coronavirus disease (COVID- 19) in China [J]. Chin J Epidemiol, 2020, 41(2): 145-151. [8] Lau H, Khosrawipour V, Kocbach P, et al. The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China [J]. Journal of Travel Medicine, 2020, 27(3): 37. [9] 湖北省卫生健康委员会. 2020年4月26日湖北省新冠肺炎疫情情况 [EB/OL]. (2020-04-26)[2020-05-11]. http://wjw.hubei.gov.cn/fbjd/dtyw/202004/t20200427_2248451.shtml. Health Commission of Hubei Province. COVID-19 outbreak in Hubei province on 26 April 2020 [EB/OL]. (2020-04-26)[2020-05-11]. http://wjw.hubei.gov.cn/fbjd/dtyw/202004/t20200427_2248451.shtml. [10] World Health Organization. 中国-世界卫生组织新型冠状病毒肺炎(COVID-19)联合考察报告 [EB/OL]. (2020-02-29)[2020-04-05].http://www.nhc.gov.cn/jkj/s3578/202002/87fd92510d094e4b9bad597608f5cc2c/files/fa3ab9461d0540c294b9982ac22af64d.pdf. World Health Organization. China-WHO joint investigation report on COVID-19 [EB/OL]. (2020-02-29)[2020-04-05].http://www.nhc.gov.cn/jkj/s3578/202002/87fd92510d094e4b9bad597608f5cc2c/files/fa3ab9461d0540c294b9982ac22af64d.pdf. [11] Read J M, Bridge J R E, Cummings D A T, et al. Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions [DB/OL]. [2020-05-07]. http://dx.doi.org/10.1101/2020.01.23.20018549. [12] Li J H, Wang Y J, Gilmour S, et al. Estimation of the epidemic properties of the 2019 novel coronavirus: a mathematical modeling study [DB/OL]. [2020-05-03].https://doi.org/10.1101/2020.02.18.20024315. [13] 中国疾病预防控制中心. 2019 新型冠状病毒疫情进展和风险评估[EB/OL]. (2020-01-28)[2020-04-11]. http://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/. Chinese Center for Disease Control and Prevention. Epidemic update and risk assessment of 2019 Novel Coronavirus [EB/OL]. (2020-01-28)[2020-04-11]. http://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/. [14] Li R Y, Pei S, Chen B, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (COVID-19)[DB/OL]. [2020-05-03]. https://doi.org/10.1101/2020.02.14.20023127. [15] Hu Z L, Song C, Xu C J, et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China [J]. Sci China Life Sci, 2020, 63: 706-711. [16] 高文静,李立明. 新型冠状病毒肺炎潜伏期或隐性感染者传播研究进展[J]. 中华流行病学杂志, 2020, 41(4): 485-488. Gao Wenjing, Li Liming. Advance on presymptomatic or asymptomatic carrier transmission of COVID-19 [J]. Chin J Epidemiol, 2020, 41(4): 485-488. [17] 湖北省卫生健康委员会. 2020年1月20日-3月29日湖北省新冠肺炎疫情情况 [EB/OL]. (2020-04-11)[2020-04-11]. http://wjw.hubei.gov.cn/. Health Commission of Hubei Province. COVID-19 outbreak in Hubei province from January 20 to March 29, 2020 [EB/OL]. (2020-03-29)[2020-04-11]. http://wjw.hubei.gov.cn/. [18] 谭红专. 关于新型冠状病毒肺炎诊断标准的流行病学思考 [DB/OL]. [2020-05-07]. http://rs.yiigle.com/yufabiao/1186813. Tan Hongzhuan. An epidemiologic thinking on the diagnosis criteria of COVID-19 [DB/OL]. [2020-05-07]. http://rs.yiigle.com/yufabiao/1186813. [19] 国家卫生健康委员会办公厅,国家中医药管理局办公室. 新型冠状病毒感染的肺炎诊疗方案(试行第三版)[EB/OL]. (2020-01-23)[2020-04-11]. http://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_11815/202001/W020200123581113562555.pdf. General Office for National Health Commission and National Administration of Traditional Chinese Medicine. The guideline of diagnosis and treatment of COVID-19 (pilot release 3) [EB/OL]. (2020-01-23)[2020-04-11]. http://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_11815/202001/W020200123581113562555.pdf. [20] 国家卫生健康委员会办公厅. 新型冠状病毒肺炎防控方案(第4版)[EB/OL]. (2020-02-07)[2020-04-11].http://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_11815/202002/W020200207737109070291.pdf. General Office for National Health Commission. Prevention and control plan of COVID-19 (4th edition) [EB/OL]. (2020-02-07)[2020-04-11]. http://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_11815/202002/W020200207737109070291.pdf. [21] 国家卫生健康委员会办公厅. 新型冠状病毒肺炎诊疗方案(试行第5版修正版)[EB/OL]. (2020-02-08)[2020-04-11]. http://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_11815/202002/W020200209352220787328.pdf. General Office for National Health Commission. The guideline of diagnosis and treatment of COVID-19 (pilot release 5 revision) [EB/OL]. (2020-02-08)[2020-04-11].http://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_11815/202002/W020200209352220787328.pdf. [22] 国家卫生健康委员会办公厅. 新型冠状病毒肺炎诊疗方案(试行第6版)[EB/OL]. (2020-02-19)[2020-04-11]. http://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_11815/202002/W020200219516971614358.pdf. General Office for National Health Commission. The guideline of diagnosis and treatment of COVID-19 (pilot release 6) [EB/OL]. (2020-02-19)[2020-04-11]. http://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_11815/202002/W020200219516971614358.pdf. [23] 国家卫生健康委员会办公厅. 新型冠状病毒肺炎防控方案(第5版)[EB/OL]. (2020-02-21)[2020-04-11].http://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_11815/202002/W020200223341563346503.pdf. General Office for National Health Commission. Prevention and control plan of COVID-19 (5th edition) [EB/OL]. (2020-02-21)[2020-04-11].http://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_11815/202002/W020200223341563346503.pdf. [24] 魏永越,卢珍珍,杜志成,等. 基于改进的SEIR+CAQ传染病动力学模型进行新型冠状病毒肺炎疫情趋势分析[J]. 中华流行病学杂志, 2020, 41(4): 470-475. Wei Yongyue, Lu Zhenzhen, Du Zhicheng, et al. Fitting and forecasting the trend of COVID-19 by SEIR+CAQ dynamic model. Chin J Epidemiol, 2020, 41(4): 470-475. [25] 国家卫生健康委员会办公厅. 新型冠状病毒肺炎防控方案(第6版)[EB/OL]. (2020-03-07)[2020-04-11]. http://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_11815/202003/W020200309376009304000.pdf. General Office for National Health Commission. Prevention and control plan of COVID-19 (6th edition) [EB/OL]. (2020-03-07)[2020-04-11].http://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_11815/202003/W020200309376009304000.pdf. [26] Li Q, Guan X H, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronaviru-infected pneumonia[J]. N Engl J Med, 2020, 382: 1199-1207. [27] Mizumoto K, Kagaya K, Zarebski A, et al. Estimating the asymptomatic of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020[J]. Euro Surveill, 2020, 25 (10): 2000180. [28] Keeling M J, Rohani P. Modeling Infectious Diseases in Humans and Animals [M]. Princeton: Princeton University Press, 2007: 19-21. [29] Tian S J, Hu N, lou J, et al. Characteristics of COVID-19 infection in Beijing[J]. Journal of Infection, 2020, 80: 401-406. [30] 陈奕,王爱红,易波,等. 宁波市新型冠状病毒肺炎密切接触者感染流行病学特征分析[J]. 中华流行病学杂志, 2020, 41(5): 668-672. Chen Yi, Wang Aihong, Yi Bo, et al. The epidemiological characteristics of infection in close contacts of COVID-19 in Ningbo city [J]. Chin J Epidemiol, 2020, 41(5): 668-672. [31] 吴尊友. 新型冠状病毒肺炎无症状感染者在疫情传播中的作用于防控策略[J]. 中华流行病学杂志, 2020, 41(6): 801-805. Wu Zunyou. Asymptomatic and pre-symptomatic cases of COVID-19 contribution to spreading the epidemic and need for targeted control strategies[J]. Chin J Epidemiol, 2020, 41(6): 801-805. [32] The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) — China[J]. CCDC Weekly, 2020, 2(8): 113,122. [33] Kiesha P, Yang L Y, Timothy W, et al. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study[J]. The Lancet, 2020, 5(5): 261-270.